Abstract
The risk of inflammatory changes, potential autoimmune diseases and breast cancer in women with breast implants are now well recognized..
Highlights
The risk of inflammatory changes, potential autoimmune diseases and breast cancer in women with breast implants are well recognized [1,2,3,4,5,6]
Given the prevalence of breast implants and the likelihood that they will not become a thing of the past, it is important that clinicians be able to monitor the overall health of the women and men with breast implants by measuring changes in breast health [7,8,9]
This study investigated the prevalence of inflammatory changes in women with breast implants and monitored those changes by measuring metabolic and Regional Blood Flow (RBF) differences associated with inflammatory and cancerous breast changes using The Fleming Method for Tissue and Vascular Differentiation and Metabolism molecular breast imaging
Summary
The risk of inflammatory changes, potential autoimmune diseases and breast cancer in women with breast implants are well recognized [1,2,3,4,5,6]. This study investigated the prevalence of inflammatory changes in women with breast implants and monitored those changes by measuring metabolic and Regional Blood Flow (RBF) differences associated with inflammatory and cancerous breast changes using The Fleming Method for Tissue and Vascular Differentiation and Metabolism molecular breast imaging. Breast implants are recognized to be associated with a variety of potential problems, including inflammatory changes – both locally and systemically–precancerous and cancerous changes. Monitoring these changes are problematic in the face of breast implants.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
